20041 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Pulmonary tract; Aromatherapy
Triptan powders for pulmonary delivery
#602Compositions and methods for treatment of short telomere disorders
#603Drug condensation aerosols and kits
#604Polyethylene glycol based prodrug of adrenomedullin and use thereof
#605Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome
#606Acyl nornicotines reduce sensory irritation in tobacco and nicotine products
#607NO/HE GAS MIXTURE WITH BACTERICIDAL ACTION
#608Use of quaternary pyridinium salts as vasoprotective agents
#609Treatment of respiratory disorders using ROR-gamma inhibitors
#610METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS
#611pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#612Process for the preparation of a PDE4 inhibitor
#613COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#614Use of inhibitors of bruton's tyrosine kinase (BTK)
#615NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN
#616Antibacterial phage, phage peptides and methods of use thereof
#617METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
#618Marker for Cancer Prognosis and Methods Related Thereto
#619Compositions and methods for treating respiratory injury or disease
#620Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#621Treating Bacterial Infections of the Lung
#622Methods of inducing anesthesia
#623METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE
#624Compositions and methods for enzymatic treatment of lung disorders
#625Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#626Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
#627System and method of administering a pharmaceutical gas to a patient
#628Electronic cigarette
#6298'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
#630Anti-fibrotic pyridinones
#631COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION- OR CHEMOTHERAPY-INDUCED PULMONARY DYSFUNCTION
#632Composition with pharmacological effect for vaporizing and method
#633COMPOSITIONS AND METHODS FOR TREATMENT OF RESPIRATORY TRACT INFECTIONS
#634Stem cell factor inhibitor
#635Pyrimidinone compounds as human neutrophil elastase inhibitors
#636Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
#637DEVICE AND METHOD FOR DELIVERY OF A MEDICAMENT
#638INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB
#639Quinine compounds, and optical isomers, preparation method and medical use thereof
#640Inhalable medicament
#641NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#642Electronic cigarette
#643Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen
#644Compounds and methods for inhibiting Cif virulence factor
#645NON-ANESTHETIC PROTECTIVE GASES IN COMBINATION WITH LIQUID ANESTHETIC AGENTS FOR ORGAN PROTECTION
#646METHODS FOR USING NITRIC OXIDE IN A PLASMA STATE TO TREAT MEDICAL CONDITIONS AND DISEASES
#647Treatment of pulmonary arterial hypertension with leukotriene inhibitors
#648TREATMENT FOR NICOTINE-INDUCED LUNG DISEASE USING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONISTS
#649NOVEL MEANS TO DECREASE THE NEGATIVE EFFECTS OF SMOKING
#650Composition for the treatment of cystic fibrosis
#651Use of inhibitors of bruton's tyrosine kinase (Btk)
#652Method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent
#653METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#654THERAPEUTIC AGENT FOR A DISEASE ACCOMPANIED BY EPILEPTIFORM DISCHARGES
#655Nicotine salt with meta-salicylic acid
#656PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ADMINISTRATION
#657COMBINATION OF XENON WITH AN NMDA RECEPTOR ANTAGONIST FOR FIGHTING A NEURODEGENERATIVE DISEASE
#658Vaporized medicants and methods of use
#659SnF2 APPLICATIONS, METHODS AND RELATED FORMULATIONS
#660Process to suspend cannabis oil in glycerin
#661Methods for diagnosing and treating asthma
#662INHIBITORS OF MITOCHONDRIAL STAT3 AND USES THEREOF IN MODULATION OF MAST CELL EXOCYTOSIS
#663HALOGENATED ETHER COMPOUNDS AND METHODS OF INDUCING ANESTHESIA
#664Pharmaceutical formulations for treating ocular conditions
#665Dry eye treatments
#666Methods of increasing tear production
#667USE OF X-RAY CONTRAST MEDIA AND RELATED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF A FILOVIRUS INFECTION
#668Methods of improving ocular discomfort
#669+L-CARNOSINE ZINC FORMULATIONS AND METHODS OF USE
#670Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
#671NITROXYL DONORS FOR THE TREATMENT OF PULMONARY HYPERTENSION
#672Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza
#673USE OF XENON FOR LIMITING TUMOR CELL MIGRATION
#674LEPTIN FOR TREATING SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
#675TREATMENTS FOR NEUROPATHY
#676DELIVERY OF ARGON TO A RECIPIENT OF BIOLOGICAL MATERIAL
#677Aromatherapy vaporization device
#678Micronutrient formulation in electronic cigarettes
#679Systems, methods, and devices to incentivize inhaler use
#680Systems, methods, and devices to incentivize inhaler use
#681Method of preventing or treating sinusitis with oxidative reductive potential water solution
#682SYSTEMS, METHODS, AND DEVICES TO INCENTIVIZE INHALER USE
#683NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#684Nicotine salt formulations for aerosol devices and methods thereof
#685Therapeutic agent for fibroid lung
#686Methods for treating respiratory diseases and formulations therefor
#687INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#688INORGANIC NITRITE TO IMPROVE CARDIOPULMONARY HEMODYNAMICS
#689Preparations, Methods And Kits Useful For The Treatment Of Cough
#690Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
#691Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#692Compounds that modulate intracellular calcium
#693Method, apparatus and kit for the treatment of neurodegenerative diseases and impairments
#694Argon is a mu opioid receptor antagonist
#695METHODS FOR PROVIDING RAPID RELIEF OF MOTOR FLUCTUATIONS IN A PARKINSON'S DISEASE PATIENT
#696Amino-pyrimidine skeletal muscle modulators
#697PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION
#698System and Method for High Concentration Nitric Oxide Delivery
#699INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#700Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof
#701Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof
#702Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof
#703Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof
#704Crystalline forms of a factor XIa inhibitor
#705ACUTE TREATMENT OF HEADACHE WITH PHENOTHIAZINE ANTIPSYCHOTICS
#706Agent for ameliorating chronic obstructive pulmonary disease
#707Medicinal carbohydrates for treatment of respiratory conditions
#708Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
#709Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#710Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
#711Inhalable medicament
#712TREATMENT OF TYPE I AND TYPE II DIABETES
#713Potentiation of glucose elimination
#714USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS
#715N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress
#716Surfactant lipids, compositions thereof, and uses thereof
#717Treatment of thrombocytopenia using orally administered interferon
#718NO/Nitrogen Gaseous Mixture With A High NO Content For The Treatment Of Severe Hypoxemic Respiratory Failure
#719Method, apparatus, and kit for the pulsing treatment of neurodegenerative diseases and impairments
#720Winterized crude cannabis extracts and methods of preparation and use
#721Kinase inhibitors
#722Methods for treating intrapulmonary infections
#723INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#724GEOMETRICALLY ENGINEERED PARTICLES AND METHODS FOR MODULATING MACROPHAGE OR IMMUNE RESPONSES
#725Dry powder formulations of dNase I
#726Inhalable liquid formulations of DNase I
#727Oral nicotine-substituted cytisine atomized liquid and its preparation method
#728Composition for electronic cigarettes
#729Aerosol generator
#730Conjugate with target-finding ligand and use thereof
#731METHODS FOR ADMINISTERING CORTICOSTEROID FORMULATIONS
#732Electronic cigarette
#733Methods and devices for lung volume reduction with extracellular matrix material
#734IL-1 binding proteins
#735LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
#736IL-1 binding proteins
#737IL-1 binding proteins
#738Smokeless THC and administration method thereof
#739Certain amino-pyrimidines, compositions thereof, and methods for their use
#740COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION- OR CHEMOTHERAPY-INDUCED PULMONARY DYSFUNCTION
#741IL-1 binding proteins
#742Use of inhibitors of bruton's tyrosine kinase (BTK)
#743Pulmonary Delivery in Treating Disorders of the Central Nervous System
#744METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASE
#745Transpulmonary liposome for controlling drug arrival
#746IL-1 binding proteins
#747Cinnamic acid-based oligomers and uses thereof
#748Method of forming an aerosol for inhalation delivery
#749Aerosol forming device for use in inhalation therapy
#750Drug condensation aerosols and kits
#751Method, apparatus and kit for the treatment of neurodegenerative diseases and impairments
#752TREATMENT OF RESPIRATORY DISEASES
#753INTRAPULMONARY BENZODIAZEPINE FOR THE TREATMENT AND PREVENTION OF SEIZURES
#754Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
#755Antimicrobial compositions and methods
#756System and method of administering a pharmaceutical gas to a patient
#757Electronic cigarette
#758Method and system for drug delivery
#759Method of forming an aerosol for inhalation delivery
#760Pheromone compositions and methods of use
#761Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#762Product and process for inhibition of biofilm development
#763System and method of administering a pharmaceutical gas to a patient
#764Therapeutic agent for pulmonary emphysema
#765METHODS OF TREATING BACTERIAL INFECTIONS THROUGH PULMONARY DELIVERY OF FUSIDIC ACID
#766Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
#767Certain amino-pyrimidines, compositions thereof, and methods for their use
#768Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
#769XENON-BASED INHALABLE DRUG FOR PREVENTING ADDICTION RELAPSES IN HUMANS
#770METHODS FOR TREATING INTRAPULMONARY INFECTIONS
#771Inhaler system for volatile substances
#772Drug condensation aerosols and kits
#773Methods for treating nicotine addiction and reducing food consumption
#774Recombinant baculovirus vaccine
#775THERAPEUTIC AGENT FOR FIBROID LUNG
#776Conjugate with target-finding ligand and use thereof
#777Stem cell factor inhibitor
#778Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
#779ELECTRONIC CIGARETTE
#780System and method of administering a pharmaceutical gas to a patient
#781Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
#782COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS
#783Use of inhibitors of bruton's tyrosine kinase (Btk)
#784Medicinal carbohydrates for treatment of respiratory conditions
#785ANTIBACTERIAL CONJUGATED BORONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#786Compositions and methods for delivery of frozen particle adhesives
#787Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#788Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
#789Compositions and methods for biological remodeling with frozen particle compositions
#790Compositions and methods for biological remodeling with frozen particle compositions
#791THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#792Electronic cigarette
#793CHEMICALLY MODIFIED SMALL MOLECULES
#794Pulmonary Delivery in Treating Disorders of the Central Nervous System
#795USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#796Treatment of allergic otitis media in mammals with neurotoxins
#797Cell-penetrating peptides
#798Method for treatment of emphysema
#799Compounds that modulate intracellular calcium
#800System and method of administering a pharmaceutical gas to a patient
#801System and method of administering a pharmaceutical gas to a patient
#802Cinnamic acid-based oligomers and uses thereof
#803Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
#804Method and Medicament for Pain Management
#805Dosing regimens and methods of treatment using carbon monoxide
#806IL-1 binding proteins
#807METAL COORDINATION COMPLEXES OF VOLATILE DRUGS
#808MARKER FOR CANCER PROGNOSIS AND METHODS RELATED THERETO
#809DELIVERY OF DRUG AMINES THROUGH AN INHALATION ROUTE
#810Use quaternary pyridinium salts as vasoprotective agents
#811DRUG CONDENSATION AEROSOLS AND KITS
#812AEROSOL FORMING DEVICE FOR USE IN INHALATION THERAPY
#813SUBSTRATES FOR DRUG DELIVERY DEVICE AND METHODS OF PREPARING AND USE
#814METHOD OF FORMING AN AEROSOL FOR INHALATION DELIVERY
#815USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS
#816Superior Control of Blood Glucose in Diabetes Treatment
#817Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
#818Treatment of sinusitis in mammals with clostridia neurotoxins
#819Pheromone compositions and methods of use
#820LIGHT inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
#821Frozen compositions and methods for piercing a substrate
#822Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
#823Use of anti-bacterial agents for the treatment of epithelial-related conditions
#824THERAPEUTIC AGENT FOR FIBROID LUNG
#825Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
#826Treatment of asthma in mammals with clostridia neurotoxins
#827Treatment of allergic rhinitis in mammals with neurotoxins
#828Treatments for Neuropathy
#829Treatment of infectious rhinitis in mammals with clostridia neurotoxins
#830POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR
#831Headache pre-emption by dihydroergotamine treatment during headache Precursor events
#832Methods of administering a mixture of fatty acids for the treatment of non-human mammals
#833Inhibitors of mammalian tight junction opening
#834POLYMERIC PHEROMONE FORMULATION AND METHOD OF USE TO CALM STRESS-RELATED BEHAVIOR IN MAMMALS OVER AN EXTENDED PERIOD OF TIME
#835NANOPARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS TO THE LUNG
#836Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1
#837Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#838Administration of interferon for prophylaxis against or treatment of pathogenic infection
#839Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
#840Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract
#841Aerosol generating method and device
#842Compositions and Methods for Ameliorating Clinical Electrical Disturbances
#843Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract
#844Polypeptides, antibody variable domains and antagonists methods for
#845POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS
#846METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES
#847Chemically modified small molecules
#848INHALATION FORMULATION FOR TREATING AND PROPHYLACTIC USE IN BACTERIA, MYCOBACTERIAL AND FUNGAL RESPIRATORY INFECTIONS
#849PH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#850Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#851METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
#852Systems, devices, and methods for making or administering frozen particles
#853Systems, devices, and methods for making or administering frozen particles
#854Use of quaternary pyridinium salts as vasoprotective agents
#855Systems, devices, and methods for making or administering frozen particles
#856Systems, devices, and methods for making or administering frozen particles
#857Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
#858Adhesive Label With Bittering Agent and Fluidifying Agents for Natural Airway Secretions
#859Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
#860Systems, devices and methods for making or administering frozen particles
#861Frozen compositions and methods for piercing a substrate
#862Compositions and methods for enzymatic treatment of lung disorders
#863Frozen compositions and methods for piercing a substrate
#864Frozen compositions and methods for piercing a substrate
#865Frozen compositions and array devices thereof
#866Compositions and methods for biological remodeling with frozen particle compositions
#867Frozen compositions and methods for piercing a substrate
#868Compositions and methods for delivery of frozen particle adhesives
#869Compositions and methods for delivery of frozen particle adhesives
#870Compositions and methods for biological remodeling with frozen particle compositions
#871Compositions and methods for biological remodeling with frozen particle compositions
#872Transpulmonary liposome for controlling drug arrival
#873Frozen piercing implements and methods for piercing a substrate
#874Frozen compositions and methods for piercing a substrate
#875Compositions and methods for administering compartmentalized frozen particles
#876Compositions and methods for administering compartmentalized frozen particles
#877Compositions and methods for delivery of frozen particle adhesives
#878Compositions and methods for therapeutic delivery with frozen particles
#879Compositions and methods for therapeutic delivery with frozen particles
#880Compositions and methods for therapeutic delivery with frozen particles
#881Compositions and methods for biological remodeling with frozen particle compositions
#882Compositions and methods for therapeutic delivery with frozen particles
#883Compositions and methods for therapeutic delivery with frozen particles
#884Compositions and methods for therapeutic delivery with frozen particles
#885Gaseous Mixture Containing O2 and N2O For Preventing Or Reducing Hyperalgesia
#886Reactant Formulations and Methods for Controlled Heating
#887PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION
#888USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS
#889ACUTE TREATMENT OF HEADACHE WITH PHENOTHIAZINE ANTIPSYCHOTICS
#890Methods for treating bronchial premalignancy and lung cancer
#891THROAT SPRAY
#892Polymer systems for lung volume reduction therapy
#893Agents that bind a target in pulmonary tissue for targeting respiratory diseases
#894Nitric oxide gel apparatus and method
#895Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists
#896Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
#897Recombinant baculovirus vaccine
#898DOG PHEROMONE FORMULATION AND DELIVERY SYSTEM
#899Respiratory drug condensation aerosols and methods of making and using them
#900Delivery of antipsychotics through an inhalation route